Commonwealth Equity Services’s Alaunos Therapeutics TCRT Stock Holding History

Commonwealth Equity Services’s Portfolio TCRT Stock Details TCRT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-344	Closed	-$4K	–	4097
2023 Q4	$4K	Buy	344 +20	+6%	+$241	﹤0.01%	3886
2023 Q3	$6K	Sell	324 -452	-58%	-$19.5K	﹤0.01%	3799
2023 Q2	$59K	Sell	776 -6	-0.8%	-$485	﹤0.01%	3644
2023 Q1	$73	Buy	782 +10	+1%	+$952	﹤0.01%	3539
2022 Q4	$75K	Sell	772 -82	-10%	-$11.9K	﹤0.01%	3462
2022 Q3	$220K	Hold	854	–	–	﹤0.01%	3085
2022 Q2	$158K	Sell	854 -162	-16%	-$15.5K	﹤0.01%	3277
2022 Q1	$99K	Sell	1,016 -41	-4%	-$5.26K	﹤0.01%	3491
2021 Q4	$172K	Buy	1,057 +73	+7%	+$16K	﹤0.01%	3346
2021 Q3	$268K	Buy	984 +542	+123%	+$166K	﹤0.01%	3025
2021 Q2	$175K	Buy	442 +141	+47%	+$65.8K	﹤0.01%	3309
2021 Q1	$162K	Sell	301 -142	-32%	-$88.4K	﹤0.01%	3183
2020 Q4	$167K	Buy	443 +133	+43%	+$52.9K	﹤0.01%	2968
2020 Q3	$117K	Buy	310 +34	+12%	+$15K	﹤0.01%	2847
2020 Q2	$136K	Sell	276 -7	-2%	-$3.12K	﹤0.01%	2718
2020 Q1	$104K	Sell	283 -2	-0.7%	-$1.03K	﹤0.01%	2578
2019 Q4	$201K	Sell	285 -43	-13%	-$29.6K	﹤0.01%	2613
2019 Q3	$210K	Sell	328 -26	-7%	-$20.6K	﹤0.01%	2517
2019 Q2	$309K	Sell	354 -30	-8%	-$20.6K	﹤0.01%	2176
2019 Q1	$222K	Sell	384 -40	-9%	-$16.7K	﹤0.01%	2388
2018 Q4	$119K	Sell	424 -4	-0.9%	-$1.58K	﹤0.01%	2461
2018 Q3	$205K	Buy	428 +13	+3%	+$5.57K	﹤0.01%	2484
2018 Q2	$188K	Buy	415 +30	+8%	+$19K	﹤0.01%	2481
2018 Q1	$226K	Hold	385	–	–	﹤0.01%	2305
2017 Q4	$239K	Buy	385 +17	+5%	+$12.2K	﹤0.01%	2235
2017 Q3	$339K	Hold	368	–	–	﹤0.01%	1879
2017 Q2	$343K	Buy	368 +66	+22%	+$64.7K	﹤0.01%	1828
2017 Q1	$287K	Sell	302 -21	-7%	-$19.6K	﹤0.01%	1887
2016 Q4	$259K	Sell	323 -18	-5%	-$16.2K	﹤0.01%	1872
2016 Q3	$288K	Buy	341 +25	+8%	+$20.1K	﹤0.01%	1748
2016 Q2	$260K	Buy	316 +5	+2%	+$5.44K	﹤0.01%	1765
2016 Q1	$346K	Buy	311 +15	+5%	+$15.4K	﹤0.01%	1540
2015 Q4	$370K	Buy	296 +11	+4%	+$18.2K	﹤0.01%	1458
2015 Q3	$386K	Buy	+285	New	+$470K	﹤0.01%	1392
2014 Q4	–	Sell	-67	Closed	-$27K	–	2158
2014 Q3	$27K	Hold	67	–	–	﹤0.01%	2041
2014 Q2	$41K	Sell	67 -23	-26%	-$12.8K	﹤0.01%	1999
2014 Q1	$62K	Hold	90	–	–	﹤0.01%	1923
2013 Q4	$59K	Hold	90	–	–	﹤0.01%	1862
2013 Q3	$53K	Buy	90 +10	+13%	+$4.51K	﹤0.01%	1800
2013 Q2	$25K	Buy	+80	New	+$22.2K	﹤0.01%	1778

Other funds holding TCRT

MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

ACM

Allred Capital Management Dallas, Texas $275M AUM 18.19% 1-Year Est. Return

Commonwealth Equity Services's TCRT Position: Q1 2024 in Review

Commonwealth Equity Services sold out of Alaunos Therapeutics (TCRT) in Q1 2024, closing a stake of 344 shares — an estimated $4K sold.

Commonwealth Equity Services first reported a position in TCRT in Q2 2013 and held it in 40 quarters. The position peaked at $386K in Q3 2015. 45 funds tracked by Wall St. Rank hold TCRT as of Q1 2024.

Commonwealth Equity Services reported no remaining Alaunos Therapeutics position as of Q1 2024 after selling out during the quarter.
Commonwealth Equity Services sold 344 Alaunos Therapeutics shares in Q1 2024, an estimated $4K.
Commonwealth Equity Services first reported a position in Alaunos Therapeutics in Q2 2013 and held it in 40 quarters.
Commonwealth Equity Services's Alaunos Therapeutics position peaked at $386K in Q3 2015.
45 funds tracked by Wall St. Rank held Alaunos Therapeutics as of Q1 2024.

Based on Commonwealth Equity Services's 13F filing for Q1 2024, filed 29 Apr 2024.